Back to search

Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors

Data up to Jan 2025

Published1992
Citations37
References37

Total Citations Per Year

Abstract

References (37)

Blood pressure, stroke, and coronary heart disease

1990 • 4,424 citations

Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1990 • 4,310 citations

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

1975 • 3,075 citations

急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2

1988 • 2,760 citations

Final Report on the Aspirin Component of the Ongoing Physicians' Health Study

1989 • 2,180 citations

Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina

1983 • 1,740 citations

Aspirin, Heparin, or Both to Treat Acute Unstable Angina

1988 • 1,290 citations

Platelet Activation in Unstable Coronary Disease

1986 • 1,161 citations

Aspirin, Sulfinpyrazone, or Both in Unstable Angina

1985 • 1,146 citations

Secondary prevention of vascular disease by prolonged antiplatelet treatment

1988 • 962 citations

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

1990 • 751 citations

A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke

1991 • 747 citations

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

1991 • 702 citations

Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty

1988 • 696 citations

Cloning and expression of cDNA for a human thromboxane A2 receptor

1991 • 680 citations

Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus

1990 • 600 citations

Clinical pharmacology of platelet cyclooxygenase inhibition.

1985 • 432 citations

Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.

1987 • 392 citations

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

1989 • 318 citations

Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites.

1981 • 244 citations

Estimated rate of thromboxane secretion into the circulation of normal humans.

1986 • 234 citations

Thromboxane A2 synthesis in pregnancy-induced hypertension

1990 • 204 citations

Paired analysis of urinary thromboxane B2 metabolites in humans

1987 • 200 citations

Biochemical evidence of platelet activation in patients with persistent unstable angina

1987 • 178 citations

Increased thromboxane biosynthesis in type IIa hypercholesterolemia.

1992 • 168 citations

Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back

1989 • 127 citations

Synthesis and structure of the platelet aggregation factor thromboxane A2

1985 • 126 citations

Dissociation of Platelet Activation and Spontaneous Myocardial Ischemia in Unstable Angina

1990 • 119 citations

Long-lived enzymatic metabolites of thromboxane B2 in the human circulation

1986 • 114 citations

Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man

1989 • 106 citations

Cigarette smoking: profiles of throm☐ane- and prostacyclin-derived products in human urine

1989 • 77 citations

Thromboxane Biosynthesis and Platelet Function in Type I Diabetes Mellitus

1988 • 77 citations

Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking.

1988 • 69 citations

Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification by cholesterol-lowering agents.

1990 • 58 citations

Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites

1986 • 51 citations

Smoking alters thromboxane metabolism in man

1991 • 32 citations

Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey

1989 • 15 citations

Cited By (0)

Loading...
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors (1992) – Trends in Cardiovascular Medicine | Metascience Observatory Explorer